Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines?

The lethality of infectious diseases has decreased due to the implementation of crucial sanitary procedures such as vaccination. However, the resurgence of pathogenic diseases in different parts of the world has revealed the importance of identifying novel, rapid, and concrete solutions for control and prevention. Edible vaccines pose an interesting alternative that could overcome some of the constraints of traditional vaccines. The term “edible vaccine” refers to the use of edible parts of a plant that has been genetically modified to produce specific components of a particular pathogen to generate protection against a disease. The aim of this review is to present and critically examine “edible vaccines” as an option for global immunization against pathogenic diseases and their outbreaks and to discuss the necessary steps for their production and control and the list of plants that may already be used as edible vaccines. Additionally, this review discusses the required standards and ethical regulations as well as the advantages and disadvantages associated with this powerful biotechnology tool.

• Publication year

  2017

• Venue

  Vaccines

• Publication date

  2017-05-30

• Fields of study

  Agricultural and Food Sciences, Medicine, Biology, Environmental Science

• Identifiers
  DOI 10.3390/vaccines5020014PMID 28556800PMCID 5492011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Mucosal Immune System for Vaccine Development

  2019influential reference
• EDIBLE VACCINES: AN ADVANCEMENT IN ORAL IMMUNIZATION

  2017cited by this paper
• Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae

  2017cited by this paper
• New Strategies Toward Edible Vaccines: An Overview

  2017influential reference
• Edible plants for oral delivery of biopharmaceuticals.

  2017cited by this paper
• Lettuce‐produced hepatitis C virus E1E2 heterodimer triggers immune responses in mice and antibody production after oral vaccination

  2017cited by this paper
• Molecular Farming for Production of Biopharmaceuticals and Edible Vaccines in Plants

  2016cited by this paper
• Need of cost-effective vaccines in developing countries: What plant biotechnology can offer?

  2016cited by this paper
• Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications

  2016cited by this paper
• IgA production requires B cell interaction with subepithelial dendritic cells in Peyer’s patches

  2016cited by this paper
• Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway

  2016cited by this paper
• CD8α(-) Dendritic Cells Induce Antigen-Specific T Follicular Helper Cells Generating Efficient Humoral Immune Responses.

  2015cited by this paper
• Plant-based vaccines for animals and humans: recent advances in technology and clinical trials

  2015cited by this paper
• Purification of monoclonal antibody against Ebola GP1 protein expressed in Nicotiana benthamiana.

  2015cited by this paper
• The Engineered Chloroplast Genome Just Got Smarter.

  2015cited by this paper
• Induction of Indoleamine 2, 3-Dioxygenase in Human Dendritic Cells by a Cholera Toxin B Subunit—Proinsulin Vaccine

  2015cited by this paper
• Farming of Plant-Based Veterinary Vaccines and Their Applications for Disease Prevention in Animals

  2015cited by this paper
• Enfermedad por el virus del Ébola

  2015cited by this paper
• Plant-made oral vaccines against human infectious diseases-Are we there yet?

  2015cited by this paper
• Different applications of virus‐like particles in biology and medicine: Vaccination and delivery systems

  2015cited by this paper
• The increasing value of plant-made proteins.

  2015cited by this paper
• Plant‐made pharmaceuticals: from ‘Edible Vaccines’ to Ebola therapeutics

  2015cited by this paper
• Current status of viral expression systems in plants and perspectives for oral vaccines development

  2015cited by this paper
• Transgenic plants: a 5-year update on oral antipathogen vaccine development

  2014cited by this paper
• Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses.

  2014cited by this paper
• Analysis of Laws Governing Combination Products, Transgenic Food, Pharmaceutical Products and their Applicability to Edible Vaccines

  2014cited by this paper
• Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine.

  2014cited by this paper
• Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies.

  2014cited by this paper
• Development and function of dendritic cell subsets.

  2014cited by this paper
• Algae-based oral recombinant vaccines

  2014influential reference
• Can plant biotechnology help break the HIV-malaria link?

  2014cited by this paper
• Age of Bioterrorism

  2014cited by this paper
• Plant Based Edible Vaccines against Poultry Diseases: a Review

  2014influential reference
• Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming

  2014cited by this paper
• The mucosal immune system for vaccine development.

  2014cited by this paper
• Generation and Analysis of Novel Plant-Derived Antibody-Based Therapeutic Molecules against West Nile Virus

  2014cited by this paper
• Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™

  2014cited by this paper
• Efficient agroinfiltration of plants for high-level transient expression of recombinant proteins.

  2013cited by this paper
• Edible vaccines against veterinary parasitic diseases--current status and future prospects.

  2013cited by this paper
• Alga-Produced Cholera Toxin-Pfs25 Fusion Proteins as Oral Vaccines

  2013cited by this paper
• High-affinity IgA needs TH17 cell functional plasticity

  2013cited by this paper
• Recent advances and safety issues of transgenic plant-derived vaccines

  2013cited by this paper
• Transgenic plants as green factories for vaccine production

  2013cited by this paper
• Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium

  2013cited by this paper
• The pEAQ vector series: the easy and quick way to produce recombinant proteins in plants

  2013cited by this paper
• Role of transgenic plants in agriculture and biopharming.

  2012cited by this paper
• Plantas modificadas genéticamente como vacunas comestibles: aspectos científicos y socioeconómicos

  2012influential reference
• GMP issues for recombinant plant-derived pharmaceutical proteins.

  2012cited by this paper
• Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein.

  2012cited by this paper
• Plant expressed coccidial antigens as potential vaccine candidates in protecting chicken against coccidiosis.

  2012cited by this paper
• Transient Expression of Hemagglutinin Antigen from Low Pathogenic Avian Influenza A (H7N7) in Nicotiana benthamiana

  2012cited by this paper
• Induction of protective immunity in chickens immunized with plant-made chimeric Bamboo mosaic virus particles expressing very virulent Infectious bursal disease virus antigen.

  2012cited by this paper
• Goblet cells deliver luminal antigen to CD103+ DCs in the small intestine

  2012cited by this paper
• Markets and Trade

  2011cited by this paper
• The next decade of vaccines: societal and scientific challenges.

  2011cited by this paper
• The release and induced immune responses of a plant-made and delivered antigen in the mouse gut.

  2011cited by this paper
• EDIBLE VACCINE: A BETTER WAY FOR IMMUNIZATION

  2011cited by this paper
• A plant‐based system for rapid production of influenza vaccine antigens

  2011cited by this paper
• Dermacentor tick attached to tympanic membrane.

  2011cited by this paper
• Follicular helper CD4 T cells (TFH).

  2011cited by this paper
• Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression.

  2011cited by this paper
• Comparative effect of carotenoid complex from Golden Neo-Life Dynamite (GNLD) and carrot extracted carotenoids on immune parameters in albino Wistar rats.

  2010cited by this paper
• Isolation of Highly Pathogenic Avian Influenza H5N1 from Table Eggs After Vaccinal Break in Commercial Layer Flock

  2010cited by this paper
• Pepper Mild Mottle Virus, a Plant Virus Associated with Specific Immune Responses, Fever, Abdominal Pains, and Pruritus in Humans

  2010cited by this paper
• Overview of expression of hepatitis B surface antigen in transgenic plants.

  2010cited by this paper
• Prevention of bubonic and pneumonic plague using plant-derived vaccines.

  2010cited by this paper
• [The study on immune responses in BALB/c mice by immunization with the transgenic Alfalfa(Medicago sativa) containing Eg95-EgA31 fusion gene of Echinococcus granulosus].

  2010cited by this paper
• Transgenic apple expressing an antigenic protein of the human respiratory syncytial virus.

  2010cited by this paper
• Heat-stable oral alga-based vaccine protects mice from Staphylococcus aureus infection.

  2010cited by this paper
• Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori.

  2010cited by this paper
• Plant‐made vaccines for humans and animals

  2010influential reference
• Transient expression systems for plant-derived biopharmaceuticals

  2010cited by this paper
• Plant-derived vaccines and other therapeutics produced in contained systems

  2010cited by this paper
• Oral transgenic plant-based vaccine for hepatitis B

  2010cited by this paper
• Vacunas e inmunización: situación mundial

  2010cited by this paper
• Immunoprotection of transgenic alfalfa (Medicago sativa) containing Eg95-EgA31 fusion gene of Echinococcus granulosus against eg protoscoleces.

  2010cited by this paper
• Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants.

  2009cited by this paper
• Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells.

  2009cited by this paper
• Plants as bioreactors for the production of vaccine antigens

  2009cited by this paper
• Plant-produced vaccines: promise and reality.

  2009cited by this paper
• Toward the Development of a Plant-Based Vaccine Against Reovirus

  2009cited by this paper
• Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics.

  2009cited by this paper
• Expression of hemagglutinin-neuraminidase glycoprotein of newcastle disease Virus in agroinfiltrated Nicotiana benthamiana plants.

  2009cited by this paper
• Synthesis and assembly of a full‐length human monoclonal antibody in algal chloroplasts

  2009cited by this paper
• Transient and stable expression of hepatitis B surface antigen in tomato (Lycopersicon esculentum L.)

  2008cited by this paper
• Immunogenicity of recombinant hepatitis B virus surface antigen fused with preS1 epitopes expressed in rice seeds

  2008cited by this paper
• High‐yield rapid production of hepatitis B surface antigen in plant leaf by a viral expression system

  2008cited by this paper
• Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer’s disease

  2008cited by this paper
• EMERGENCIA EN EUROPA DE LA DIFTERIA Y LA POLIOMELITIS

  2008cited by this paper
• Expression of Cholera Toxin B Subunit in Transgenic Rice Endosperm

  2008cited by this paper
• Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic.

  2008cited by this paper
• Edible vaccines: current status and future.

  2007cited by this paper
• Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens.

  2007cited by this paper
• Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine.

  2007cited by this paper
• A new highly effective anticysticercosis vaccine expressed in transgenic papaya.

  2007cited by this paper
• A launch vector for the production of vaccine antigens in plants

  2007cited by this paper
• Cholera toxin B protein in transgenic tomato fruit induces systemic immune response in mice

  2007cited by this paper
• Recombination and expression of classical swine fever virus (CSFV) structural protein E2 gene in Chlamydomonas reinhardtii chroloplasts.

  2007cited by this paper
• Molecular farming on the rise--GMO regulators still walking a tightrope.

  2007cited by this paper
• Synthesis and assembly of Escherichia coli heat-labile enterotoxin B subunit in transgenic lettuce (Lactuca sativa).

  2007cited by this paper

• Plant production systems for recombinant immunotherapeutic proteins

  2025cites this paper
• Plant and probiotic-based edible vaccines for Helicobacter pylori: Research status and application prospects.

  2025cites this paper
• How Can Plant-Derived Natural Products and Plant Biotechnology Help Against Emerging Viruses?

  2025cites this paper
• Immunogenic Potential of Chitosan Nanoparticles Encapsulating Recombinant SlyB Antigen of Enterotoxigenic Escherichia coli (ETEC) in an Animal Model.

  2025cites this paper
• Insights into the world of edible vaccines: From lab to reality

  2025cites this paper
• Advancements in Transient Overexpression Systems for Enhanced Recombinant Protein Production in Lettuce.

  2025cites this paper
• Application of Edible Vaccines

  2025cites this paper
• Molecular Farming for Immunization: Current Advances and Future Prospects in Plant-Produced Vaccines

  2025cites this paper
• Transforming Aquaculture through Vaccination: A Review on Recent Developments and Milestones

  2024cites this paper
• Tomato-made edible COVID-19 vaccine TOMAVAC induces neutralizing IgGs in the blood sera of mice and humans

  2024influential citation
• Recent Progress and Challenges in the Development of Edible Vaccines Produced by Genetically Modified Plants.

  2023cites this paper
• Recent advances in expression and purification strategies for plant made vaccines

  2023cites this paper
• EDIBLE VACCINE IS A NATURAL WAY OF VACCINATION: A REVIEW ARTICLE

  2023cites this paper
• Edible vaccines: Current scenario and future prospects

  2022cites this paper
• Conventional and nontraditional delivery methods and routes of vaccine administration

  2022cites this paper
• Immunomodulatory potential of vegetables vis-à-vis human health

  2022cites this paper
• A Comprehensive Review on Edible Vaccine

  2022cites this paper
• Emerging trends of edible vaccine therapy for combating human diseases especially COVID‐19: Pros, cons, and future challenges

  2022cites this paper
• The C3d-fused foot-and-mouth disease vaccine platform overcomes maternally-derived antibody interference by inducing a potent adaptive immunity

  2022cites this paper
• Plant Molecular Farming: Applications and New Directions

  2022cites this paper
• Insight of oral vaccines as an alternative approach to health and disease management: An innovative intuition and challenges

  2021cites this paper
• The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta

  2021cites this paper
• Cloning and Expression of Vacuolating Cytotoxin A (VacA) Antigenic Protein in Nicotiana benthamiana Leaves a Potential Source of the Vaccine against Helicobacter pylori

  2021cites this paper
• Food biopharmaceuticals as part of a sustainable bioeconomy: Edible vaccines case study.

  2020cites this paper
• Plant-based vaccines and antibodies to combat COVID-19: current status and prospects

  2020cites this paper
• GENETIC TRANSFORMATION OF CARROT (DAUCAS CAROTA L.) TO EXPRESS HEPATITIS B SURFACE ANTIGEN GENE FOR EDIBLE VACCINE OF HBV

  2020cites this paper
• Advanced Foot-And-Mouth Disease Vaccine Platform for Stimulation of Simultaneous Cellular and Humoral Immune Responses

  2020cites this paper
• A Common Food Glycan, Pectin, Shares an Antigen with Streptococcus pneumoniae Capsule

  2020cites this paper
• The Immunogenicity of a Novel Chimeric Hemagglutinin-Neuraminidase-Fusion Antigen from Newcastle Disease Virus by Oral Delivery of Transgenic Canola Seeds to Chickens

  2020cites this paper
• Effects of diet on skin sensitization by nickel, poison ivy, and sesquiterpene lactones.

  2020cites this paper
• Engineering Plants as Platforms for Production of Vaccines

  2020cites this paper
• Use of Veterinary Vaccines for Livestock as a Strategy to Control Foodborne Parasitic Diseases

  2020cites this paper
• Food biopharmaceuticals as part of a sustainable bioeconomy: edible vaccines case study.

  2020cites this paper
• A cross talk between the immunization and edible vaccine: Current challenges and future prospects

  2020cites this paper
• An AMA1/MSP119 Adjuvanted Malaria Transplastomic Plant-Based Vaccine Induces Immune Responses in Test Animals

  2020cites this paper
• Green synthesis of triclinic (anorthic) phase AgCoPO4 nanoparticles: optical studies and theoretical modelling

  2020cites this paper
• Plant Platform for Therapeutic Monoclonal Antibody Production

  2019cites this paper
• Edible Vaccines: Promises and Challenges

  2019cites this paper
• Oral immunization with a plant-derived chimeric protein in mice: Toward the development of a multipotent edible vaccine against E. coli O157: H7 and ETEC.

  2019cites this paper
• Production of recombinant colicin M in Nicotiana tabacum plants and its antimicrobial activity

  2019cites this paper
• The Molecular Approach behind Biotechnological Common Problems

  2019cites this paper
• Mucosal vaccines and technology

  2019cites this paper
• Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

  2019cites this paper
• A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals

  2019cites this paper
• Transgenic carrot plant-made edible vaccines against human infectious diseases

  2018cites this paper
• Noninvasive vaccination against infectious diseases

  2018cites this paper
• Genetically modified foods: Pros and cons for human health

  2018cites this paper